Sevelamer Carbonate Tablet, Film Coated
Product Images NDC 58624-5001

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Sevelamer Carbonate (NDC 58624-5001). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Shandong Xinhua Pharmaceutical Co., Ltd., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Label 01)

Chemical structure diagram of sevelamer carbonate showing repeating polymer units with ammonium, amine, and hydroxyl functional groups, consistent with a polymeric amine compound used as an active ingredient.*

FDA Label Image

Figure 2 (Label 02)

A forest plot comparing the effects of Sevelamer Carbonate versus placebo across various subgroups including Screening BSA, Baseline Serum Phosphorus, Age, and Dialysis status. The plot displays mean differences and 95% confidence intervals favoring Sevelamer Carbonate on the left side and placebo on the right.*

FDA Label Image

Figure 3 (Label 03)

A line graph showing percentage of patients with at least a 2-fold reduction in serum phosphorus levels (mg/dL). The graph compares the effects of Sevelamer Hydrochloride and an Active Control on phosphorus level reduction, with the x-axis indicating reduction from baseline and the y-axis showing percentage of patients. The graph highlights the progression from worsened increase to improved reduction in serum phosphorus.*

FDA Label Image

Figure 4 (Label 04)

A line graph depicting the change in phosphorus levels from baseline over a 52-week study period. The x-axis represents study weeks, while the y-axis represents phosphorus change from baseline. Two treatment groups are shown: Sevelamer Hydrochloride and Active-Control, with phosphorus levels decreasing and stabilizing over time.*

FDA Label Image

Package Label (Principal Display Panel)

Label for Sevelamer Carbonate tablets, film coated, 800 mg strength. The label indicates the product is for prescription use only and contains 30 film-coated tablets. The manufacturer is Shandong Xinhua Pharmaceutical Co., Ltd., located in Zibo, Shandong, China. The label includes storage instructions, a barcode, and a QR code.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.